Evaluation of Salivary RNA in Subjects Scheduled for Surgery for a Gynecologic Pathology

RecruitingOBSERVATIONAL
Enrollment

2,500

Participants

Timeline

Start Date

December 5, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Gynecologic DiseaseGynecologic CancerEndometriosisOvarian CancerCyst OvaryFibroidCervical CancerUterine Cancer
Interventions
DIAGNOSTIC_TEST

Saliva sample

Saliva sample

Trial Locations (13)

14033

RECRUITING

CHU Caen, Caen

Unknown

NOT_YET_RECRUITING

CHU d'Angers, Angers

RECRUITING

Clinique Tivoli Ducos - IFEMENDO, Bordeaux

NOT_YET_RECRUITING

Institut Bergonié, Bordeaux

NOT_YET_RECRUITING

CGFL, Dijon

NOT_YET_RECRUITING

CHU Lyon Sud, Lyon

NOT_YET_RECRUITING

American Hospital of Paris, Neuilly-sur-Seine

NOT_YET_RECRUITING

CHU de Rennes Site Hôpital Sud, Rennes

NOT_YET_RECRUITING

Clinique La sagesse, Rennes

RECRUITING

CHU Rouen, Rouen

RECRUITING

Clinique Pasteur, Toulouse

RECRUITING

CHU Bretonneau-Tours, Tours

NOT_YET_RECRUITING

Institut Gustave Roussy, Villejuif

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Monitoring Force Group

INDUSTRY

lead

ZIWIG

INDUSTRY